Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 8.

Journal Article

Braegelmann, Johannes, Lorenz, Carina, Borchmann, Sven ORCID: 0000-0001-6662-6864, Nishii, Kazuya, Wegner, Julia ORCID: 0000-0001-8103-8040, Meder, Lydia, Ostendorp, Jenny, Ast, David F., Heimsoeth, Alena, Nakasuka, Takamasa, Hirabae, Atsuko, Okawa, Sachi, Dammert, Marcel A., Plenker, Dennis, Klein, Sebastian ORCID: 0000-0002-2188-9377, Lohneis, Philipp, Gu, Jianing, Godfrey, Laura K., Forster, Jan, Trajkovic-Arsic, Marija, Zillinger, Thomas, Haarmann, Mareike, Quaas, Alexander, Lennartz, Stefanie, Schmiel, Marcel, D'Rozario, Joshua, Thomas, Emily S., Li, Henry, Schmitt, Clemens A. ORCID: 0000-0002-4731-2226, George, Julie, Thomas, Roman K., von Karstedt, Silvia, Hartmann, Gunther, Buettner, Reinhard, Ullrich, Roland T., Siveke, Jens T., Ohashi, Kadoaki, Schlee, Martin ORCID: 0000-0003-3671-7639 and Sos, Martin L. (2021). MAPK-pathway inhibition mediates inflammatory reprogramming and sensitizes tumors to targeted activation of innate immunity sensor RIG-I. Nat. Commun., 12 (1). BERLIN: NATURE PORTFOLIO. ISSN 2041-1723

Dorneburg, Carmen, Goss, Annika V., Fischer, Matthias, Roels, Frederik, Barth, Thomas F. E., Berthold, Frank, Kappler, Roland ORCID: 0000-0002-8581-2803, Oswald, Franz, Siveke, Jens T., Molenaar, Jan J., Debatin, Klaus-Michael ORCID: 0000-0002-8397-1886 and Beltinger, Christian (2016). gamma-secretase inhibitor I inhibits neuroblastoma cells, with NOTCH and the proteasome among its targets. Oncotarget, 7 (39). S. 62799 - 62814. ORCHARD PARK: IMPACT JOURNALS LLC. ISSN 1949-2553

Kunzmann, Volker, Martens, Uwe Marc, Alguel, Hana, Siveke, Jens T., Goekkurt, Eray, Pelzer, Uwe ORCID: 0000-0001-9213-2737, Siegler, Gabriele Margareta, Hennes, Elke, Waldschmidt, Dirk, Jakobs, Ralf, Ferenczy, Peter, Keller, Ralph, Boeck, Stefan Hubert, Kullmann, Frank, Kapp, Markus and Germer, Christoph Thomas (2018). Secondary resectability in locally advanced pancreatic cancer (LAPC) after nab-paclitaxel/gemcitabine- versus FOLFIRINOX-based induction chemotherapy: Interim results of a randomized phase II AIO trial (NEOLAP). J. Clin. Oncol., 36 (4). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755

Kunzmann, Volker, Siveke, Jens T., Alguel, Hana, Goekkurt, Eray, Siegler, Gabriele, Martens, Uwe, Waldschmidt, Dirk, Pelzer, Uwe ORCID: 0000-0001-9213-2737, Fuchs, Martin, Kullmann, Frank, Boeck, Stefan, Ettrich, Thomas J., Held, Swantje, Keller, Ralph, Klein, Ingo, Germer, Christoph-Thomas, Stein, Hubert, Friess, Helmut, Bahra, Marcus, Jakobs, Ralf, Hartlapp, Ingo and Heinemann, Volker (2021). Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial. Lancet Gastroenterol. Hepatol., 6 (2). S. 128 - 139. SAN DIEGO: ELSEVIER INC. ISSN 2468-1253

Striefler, Jana K., Reissig, Timm M., Kunzmann, Volker, Westphalen, C. Benedikt, Boeck, Stefan, Ettrich, Thomas J., Lutz, Manfred P., Waldschmidt, Dirk T., Brunner, Thomas, Uhl, Waldemar, Sinn, Marianne and Siveke, Jens T. (2022). Pancreatic cancer Clinical research projects of the German oncology groups (ACO, AIO, and ARO). Onkologe, 28 (SUPPL 1). S. 30 - 36. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1433-0415

Vogel, Arndt, Kasper, Stefan ORCID: 0000-0002-5947-8733, Bitzer, Michael, Block, Andreas, Sinn, Marianne, Schulze-Bergkamen, Henning, Moehler, Markus, Pfarr, Nicole, Endris, Volker, Goeppert, Benjamin ORCID: 0000-0002-4135-9250, Merx, Kirsten, Schnoy, Elisabeth, Siveke, Jens T., Michl, Patrick, Waldschmidt, Dirk, Kuhlmann, Jan, Geissler, Michael, Kahl, Christoph, Evenkamp, Ralph, Schmidt, Torben, Kuhlmann, Alexander, Weichert, Wilko and Kubicka, Stefan (2018). PICCA study: panitumumab in combination with cisplatin/gemcitabine chemotherapy in KRAS wild-type patients with biliary cancer-a randomised biomarker-driven clinical phase II AIO study. Eur. J. Cancer, 92. S. 11 - 20. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852

Westphalen, Benedikt C., Bokemeyer, Carsten, Buettner, Reinhard, Froehling, Stefan, Gaidzik, Verena I., Glimm, Hanno, Hacker, Ulrich T., Heinemann, Volker, Illert, Anna L., Keilholz, Ulrich, Kindler, Thomas, Kirschner, Martin, Schilling, Bastian ORCID: 0000-0001-8859-4103, Siveke, Jens T., Schroeder, Thomas, Tischler, Verena ORCID: 0000-0002-6673-8329, Wagner, Sebastian, Weichert, Wilko, Zips, Daniel and Loges, Sonja (2020). Conceptual framework for precision cancer medicine in Germany: Consensus statement of the Deutsche Krebshilfe working group 'Molecular Diagnostics and Therapy'. Eur. J. Cancer, 135. S. 1 - 8. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852

Westphalen, C. Benedikt, Bokemeyer, Carsten, Buettner, Reinhard, Froehling, Stefan, Gaidzik, Verena I., Glimm, Hanno, Hacker, Ulrich T., Heinemann, Volker, Illert, Anna L., Keilholz, Ulrich, Kindler, Thomas, Kirschner, Martin, Schilling, Bastian, Siveke, Jens T., Schroeder, Thomas, Tischler, Verena, Wagner, Sebastian, Weichert, Wilko, Zips, Daniel and Loges, Sonja (2022). Conceptual framework for precision cancer medicine in Germany: Consensus statement of the Deutsche Krebshilfe working group 'Molecular Diagnostics and Therapy (vol 135, pg 1, 2020). Eur. J. Cancer, 162. S. 245 - 247. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852

This list was generated on Fri Apr 19 10:17:59 2024 CEST.